Source: Annual Congress 2009 - Functional insights into COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Pavlenko, T. Pertseva, O. Lykholat (Dnepropetrovsk, Ukraine). Effects of n acetylcystein on proteinas-inhibitory system with chronic bronchitis. Eur Respir J 2009; 34: Suppl. 53, 3817

Member's Comments

No comment yet.

Related content which might interest you: Effects of N-acetylcystein on proteinas-inhibitory system in smokers with chronic obstructive bronchitis (COB) Source: Eur Respir J 2003; 22: Suppl. 45, 52s Year: 2003 Pharmacodynamics of levofloxicin in patients with acute exacerbation of chronic bronchitis Source: Eur Respir J 2002; 20: Suppl. 38, 546s Year: 2002 Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis Source: Eur Respir Rev 2015; 24: 451-461 Year: 2015 Rheoplasty in chronic bronchitis Source: Virtual Congress 2021 – Interventional pulmonology Year: 2021 Mechanisms of persistence of Streptococcus pneumoniae following treatment of acute exacerbation of chronic bronchitis Source: Annual Congress 2009 - Exacerbations of COPD: new findings Year: 2009 Acute bronchitis: aetiology and treatment Source: Eur Respir Monogr 2013; 60: 1-17 Year: 2013 Mucoactive therapy in COPD Source: Eur Respir Rev 2009; 19: 134-140 Year: 2010 Efficacy of erdosteine (E) in the treatment of exacerbated and stable chronic bronchitis or chronic obstructive pulmonary disease (CB/COPD): a meta-analysis of individual patient data Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Bacterial extract (OM-85) preventive effect in chronic bronchitis complicated with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 578s Year: 2005 Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Efficacy and cardiovascular safety of long-term bronchodilator therapy with theophylline in patients with chronic obstructive bronchitis (COB) Source: Eur Respir J 2003; 22: Suppl. 45, 52s Year: 2003 Health status following an acute exacerbation of chronic bronchitis (AECB) is better in patients receiving gemifloxacin compared with clarithromycin Source: Eur Respir J 2001; 18: Suppl. 33, 542s Year: 2001 Changes in bronchial inflammation during acute exacerbations of chronic bronchitis Source: Eur Respir J 2001; 17: 1112-1119 Year: 2001 Molecular epidemiology of acute exacerbations of chronic bronchitis (AECB) Source: Annual Congress 2009 - Exacerbations of COPD: new findings Year: 2009 Efficacy of azithromycin vs. ciprofloxacin in the treatment of patients with acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 544s Year: 2002 Treatment of chronic cough with morphine Source: Eur Respir J 2006; 28: Suppl. 50, 437s Year: 2006 Comparison of the efficacy of azythromycin and roxithromycin in the treatment of acute purulent exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 138s Year: 2001 Effects of inhaled corticosteroids on airway inflammations of different types in patients with chronic obstructive pulmonary disease or asthma in stable phase Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009